Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.) is a listed company. Filings by its managers are published through SEDI. The past year has been quiet: not a single insider filing for Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.). The previous disclosure was published on 21 February 2023.
Since 2022, the database holds 4 purchases and 8 sales by insiders of the company.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
19 of 19 declarations
Nirvana Life Sciences Inc. is a life sciences company focused on developing therapeutic products. Formerly known as Endocan Solutions Inc., it is listed on the XTSE.